おかえりなさい
Click “ログイン” to agree to Cointime’s 利用規約 and acknowledge that Cointime’s プライバシーポリシー applies to you.
アカウント登録
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">利用規約</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">プライバシーポリシー</a> applies to you.
siteでログインする
siteで登録する
あなたのメールアドレス
受信トレイを確認する
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Myovant Sciences
company
About
Myovant Sciences is a biotech company that develops new treatments for infertility in women and prostate cancer in men.
- 501 - 1000
Highlights
Details
- Last Funding Type
- Post-IPO Debt
- Last Funding Money Raised
- $40M
- Industries
- Biotechnology,Health Care,Life Science,Men's,Women's
- Founded date
- Jan 1, 2016
- Number Of Employee
- 501 - 1000
- Operating Status
- Active
Myovant Sciences is a biotech company that develops new treatments for infertility in women and prostate cancer in men. The company's product capabilities and help continue to deliver innovative therapies addressing unmet patient needs in prostate cancer and women’s health.Myovant Sciences was established in 2016 and is based in Brisbane, California.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$40M
Myovant Sciences has raised a total of
$40M
in funding over 2 rounds. Their latest funding was raised on
Oct 16, 2017 from a Post-IPO Debt round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Oct 16, 2017 | Post-IPO Debt | $40M | 1 |
Hercules Capital
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
Myovant Sciences is funded by 1 investors.
Hercules Capital
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Hercules Capital
|
Yes | Post-IPO Debt |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
